Abstract
The antibacterial activity of RU 64004, a new ketolide, was evaluated against more than 600 bacterial strains and was compared with those of various macrolides and pristinamycin. RU 64004 had good activity against multiresistant pneumococci, whether they were erythromycin A resistant or not, including penicillin-resistant strains. RU 64004 inhibited 90% of pneumococci resistant to erythromycin A and penicillin G at 0.6 and 0.15 microg/ml, respectively. Unlike macrolides, RU 64004 did not induce the phenotype of resistance to macrolides-lincosamides-streptogramin B. Its good antibacterial activity against multiresistant pneumococci ran in parallel with its well-balanced activity against all bacteria involved in respiratory infections (e.g., Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pyogenes). In contrast to all comparators (14- and 16-membered-ring macrolides and pristinamycin), RU 64004 displayed high therapeutic activity in animals infected with all major strains, irrespective of the phenotypes of the strains. The results suggest that RU 64004 has potential for use in the treatment of infections caused by respiratory pathogens including multiresistant pneumococci.
Full Text
The Full Text of this article is available as a PDF (232.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Appelbaum P. C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992 Jul;15(1):77–83. doi: 10.1093/clinids/15.1.77. [DOI] [PubMed] [Google Scholar]
- Bonnefoy A., Girard A. M., Agouridas C., Chantot J. F. Ketolides lack inducibility properties of MLS(B) resistance phenotype. J Antimicrob Chemother. 1997 Jul;40(1):85–90. doi: 10.1093/jac/40.1.85. [DOI] [PubMed] [Google Scholar]
- Chantot J. F., Bryskier A., Gasc J. C. Antibacterial activity of roxithromycin: a laboratory evaluation. J Antibiot (Tokyo) 1986 May;39(5):660–668. doi: 10.7164/antibiotics.39.660. [DOI] [PubMed] [Google Scholar]
- Deguchi K., Yokota N., Koguchi M., Suzuki Y., Suzuki K., Fukayama S., Ishihara R., Oda S. [Antibacterial activity of rokitamycin against fresh clinical isolates]. Jpn J Antibiot. 1992 Dec;45(12):1609–1621. [PubMed] [Google Scholar]
- Ednie L. M., Spangler S. K., Jacobs M. R., Appelbaum P. C. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob Agents Chemother. 1997 May;41(5):1033–1036. doi: 10.1128/aac.41.5.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fernandes P. B., Bailer R., Swanson R., Hanson C. W., McDonald E., Ramer N., Hardy D., Shipkowitz N., Bower R. R., Gade E. In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother. 1986 Dec;30(6):865–873. doi: 10.1128/aac.30.6.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hara K. [New antimicrobial agent series, XXVII: Rokitamycin]. Jpn J Antibiot. 1987 Nov;40(11):1851–1860. [PubMed] [Google Scholar]
- Hyder S. L., Streitfeld M. M. Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes. Antimicrob Agents Chemother. 1973 Sep;4(3):327–331. doi: 10.1128/aac.4.3.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jamjian C., Biedenbach D. J., Jones R. N. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrob Agents Chemother. 1997 Feb;41(2):454–459. doi: 10.1128/aac.41.2.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jorgensen J. H., Redding J. S., Maher L. A., Howell A. W. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol. 1987 Nov;25(11):2105–2113. doi: 10.1128/jcm.25.11.2105-2113.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Retsema J., Girard A., Schelkly W., Manousos M., Anderson M., Bright G., Borovoy R., Brennan L., Mason R. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987 Dec;31(12):1939–1947. doi: 10.1128/aac.31.12.1939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schülin T., Wennersten C. B., Moellering R. C., Jr, Eliopoulos G. M. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. Antimicrob Agents Chemother. 1997 May;41(5):1196–1202. doi: 10.1128/aac.41.5.1196. [DOI] [PMC free article] [PubMed] [Google Scholar]